Aethlon Medical (AEMD) Cash from Investing Activities (2010 - 2026)
Aethlon Medical's (AEMD) quarterly Cash from Investing Activities came in at -$2051.0 in Q1 2026, down 193.57% YoY from $2192.0 in Q1 2025, and down 193.57% on a QoQ basis from $2192.0 in Q1 2025.
Aethlon Medical (AEMD) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Aethlon Medical (AEMD) has 16 years of Cash from Investing Activities data on file, last reported at -$2051.0 in Q1 2026.
- Quarterly Cash from Investing Activities fell 193.57% year-over-year to -$2051.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2051.0 (changed N/A YoY) and the FY2026 annual result came in at -$3704.0, changed N/A from the prior year.
- Cash from Investing Activities declined to -$2051.0 in Q1 2026, from $2192.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $2192.0 in Q1 2025 to a low of -$739165.0 in Q3 2022.
- A 5-year average of -$117368.8 and a median of -$10048.0 in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 3944.91% — and 2025, when it soared 144.67%.
- Tracing AEMD's Cash from Investing Activities over 5 years: stood at -$151486.0 in 2022, then surged by 94.19% to -$8807.0 in 2023, then jumped by 75.11% to -$2192.0 in 2024, then surged by 200.0% to $2192.0 in 2025, then tumbled by 193.57% to -$2051.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$2051.0 (Q1 2026), $2192.0 (Q1 2025), and -$2192.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Aethlon Medical | 1.04 Mn | 1.04 Mn | - | -9,150.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9,150.00 |
| Jun 30, 2026 | -9,150.00 |
| Mar 31, 2026 | -2,051.00 |
| Mar 31, 2026 | -2,051.00 |
| Mar 31, 2025 | 2,192.00 |
| Mar 31, 2025 | 2,192.00 |
| Dec 31, 2024 | -2,192.00 |
| Dec 31, 2024 | -2,192.00 |
| Mar 31, 2024 | -4,907.00 |
| Mar 31, 2024 | -4,907.00 |
| Dec 31, 2023 | -8,807.00 |
| Dec 31, 2023 | -8,807.00 |
| Sep 30, 2023 | -6,770.00 |
| Sep 30, 2023 | -6,770.00 |
| Jun 30, 2023 | -230,383.00 |
| Jun 30, 2023 | -230,383.00 |
| Mar 31, 2023 | -11,289.00 |
| Mar 31, 2023 | -11,289.00 |
| Dec 31, 2022 | -151,486.00 |
| Dec 31, 2022 | -151,486.00 |